Cytovale
Manufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
2 Tower Pl Fl 18, South San Francisco, C...Phone Number
(415) 417-2188Website
www.cytovale.comRevenue
$32.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
3
1
1
1
1
About Cytovale
Cytovale, founded in 2013 and based in San Francisco, California, is a medical technology company specializing in diagnostics using cell mechanics and machine learning, and applying this to treat sepsis.Explore more
Cytovale Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cytovale your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Cytovale has new funding data
Cytovale, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Cytovale has recently received funding, and reach out quickly before it becomes old news!
Click to see if Cytovale had a recent Job posting/layoffs
Earning: See what the market has to say on Cytovale recently announced quarterly report
Product Launch: Get notified when Cytovale launches new products
Check out if Cytovale is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Cytovale
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Cytovale
Compare insights from companies similar to Cytovale, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$22.2M
51-200
Private
$10M
2015
AD
Alicia DillardAssociate Clinical Laboratory Director and Molecular Pathologist
$7.3M
11-50
Private
$19.1M
2009
JG
Jennifer GassmanRegional Director, Implementation & Clinical Outcomes
Company Profile Activity
Activity Insights
Cytovale is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Cytovale is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Cytovale.
Cytovale financials insights
Gather financial insights about Cytovale, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Series A
$4.3M
2019
Series B
$15M
2020
Debt
$350K
2022
Unspecified
$9M
2023
Series C
$84M
2024
Series D
$100M
Cytovale Tech Stack
A closer look at the technologies used by Cytovale
See more technologies
Most Recent Scoops
Open Position
Open Position
New Hire
Executive Move
Executive Moves, New Hire
Open Position
Open Position
Cytovale News & Media
Peer-Reviewed Study Shows IntelliSep Influences ED Physicians' Sepsis Diagnostic Decisions
New multicenter analysis highlights IntelliSep's clinical usability and impact on frontline physician decision-making, strengthening existing real-world evidence SAN FRANCISCO, March 30, 2026 /PRNewswire/ -- A new peer-reviewed study published in JACEP Open found that providing emergency...Multicenter Study Shows Reproducible Clinical and Operational Gains Following Expansion of IntelliSep Sepsis Test Across Health System
SCCM 2026 presentation reports 19% reduction in sepsis mortality and double-digit operational improvements across four hospitals SAN FRANCISCO and CHICAGO, March 23, 2026 /PRNewswire/ -- Cytovale® today announced new multicenter, real-world data demonstrating that clinical and operational...Cytovale's IntelliSep® Named Modern Healthcare's Best in Business for Second Consecutive Year
Cytovale's IntelliSep® rapid sepsis test spotlighted for its innovative approach to sepsis care and demonstrated real-world impact in helping hospitals save lives SAN FRANCISCO and CHICAGO, Jan. 12, 2026 /PRNewswire/ -- Cytovale®, a commercial-stage medical diagnostics company focused on...Rapid Sepsis Test Enables Hospital to Reduce Mortality by 42% and Shorten Hospital Stay by Two Days, According to Academic Medical Center Study
Froedtert Hospital results reinforce growing real-world evidence that IntelliSep® is a transformative tool for suspected infections in emergency departments SAN FRANCISCO and ANAHEIM, Calif., Dec. 10, 2025 /PRNewswire/ -- A new study from Froedtert Hospital, an academic medical center in...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cytovale
Sign Up For FreeTo access detailed company insights
Cytovale, founded in 2013 and based in San Francisco, California, is a medical technology company specializing in diagnostics using cell mechanics and machine learning, and applying this to treat sepsis.... Read More
